Explore the vast range of titles available.

This paper proposes a novel model-free reinforcement learning (RL) control algorithm for a semi-active tunable vibration absorber (TVA) with nonlinear properties that are operated under nonstationary and multi-frequency excitations. The research addresses two critical challenges in vibration absorber control that are often treated separately: (i) the time-varying and nonlinear stiffness-damping characteristics, and (ii) the complex and nonstationary nature of real-world excitations. To address these challenges, a modified Q-learning algorithm is proposed by integrating vibration-domain knowledge derived from Parseval’s theorem and frequency response functions. This integration not only enables the controller to effectively minimize vibration energy without requiring an explicit model of the plant but also significantly reduces the computational complexity of the learning process. The proposed controller is experimentally validated under nonstationary multi-frequency excitation using a semi-active TVA with highly time-variant stiffness and damping properties. Experimental results demonstrated accurate real-time control performance, achieving an R-squared value of 0.994 compared to an optimal control baseline, and up to 58% reduction in vibration energy. These results provide strong evidence that reinforcement learning control strategies, when guided by vibration-domain knowledge, can offer generalizable, efficient, and adaptive solutions to complex mechanical vibration control problems.

Magnetorheological gel (MRG) is a smart material that can change its stiffness property by external magnetic field and has been applied as a smart rubber in suppressing vibration. Recent studies show that the electrical resistance of MRG also can be affected with external magnetic field. Thus, this study aimed to conduct analysis on MRG resistance variation due to external magnetic field with DC and AC input voltage. With an DC input voltage, the resistance change due to magnetic field was modeled. In addition, the capacitance variation of the material was observed. The impedance of MRG due to AC input voltage was analyzed and was observed that the impedance of MRG was affected by both the magnetic field and the input frequency. With the experiment data, the impedance modeling of MRG in frequency domain was derived. Based on experiment results, the performance and limitation of MRG as a magnetometer sensor are discussed.

Portulaca oleracea is as a medicinal plant known for its neuroprotective, hepatoprotective, antidiabetic, antioxidant, anticancer, antimicrobial, antiulcerogenic, and anti-inflammatory activities. However, the specific active compounds responsible for the individual pharmacological effects of P. oleracea extract (95% EtOH) remain unknown. Here, we hypothesized that alkaloids, the most abundant constituents in P. oleracea extract, are responsible for its anti-inflammatory activity. We investigated the phytochemical substituents (compounds 1–22) using nuclear magnetic resonance (NMR) and electrospray ionization mass spectrometry (ESI-MS) and screened their effects on NO production in lipopolysaccharide (LPS)-induced macrophages. Compound 20, 1-carbomethoxy-β-carboline, as an alkaloid structure, ameliorated nitric oxide (NO) production, inducible nitric oxide synthase (iNOS), and proinflammatory cytokines associated with the mitogen-activated protein kinase (MAPK) pathways, p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK). Subsequently, we observed that compound 20 suppressed nuclear translocation of nuclear factor κB (NF-κB) using immunocytochemistry. Moreover, we recently reported that compound 8, trans-N-feruloyl-3’, 7’-dimethoxytyramine, was originally purified from P. oleracea extracts. Our results suggest that 1-carbomethoxy-β-carboline, the most effective anti-inflammatory agent among alkaloids in the 95% EtOH extract of P. oleracea, was suppressing the MAPK pathway and nuclear translocation of NF-κB. Therefore, P. oleracea extracts and specifically 1-carbomethoxy-β-carboline may be novel therapeutic candidates for the treatment of inflammatory diseases associated with the activation of MAPKs and NF-κB.

Osteoporosis is characterized by the deterioration of bone structures and decreased bone mass, leading to an increased risk of fracture. Estrogen deficiency in postmenopausal women and aging are major factors of osteoporosis and are some of the reasons for reduced quality of life. In this study, we investigated the effects of n-trans-hibiscusamide (NHA) and its derivative 4-O-(E)-feruloyl-N-(E)-hibiscusamide (HAD) on receptor activator of nuclear factor kappa-Β (NF-κB) ligand (RANKL)-induced osteoclast differentiation and an ovariectomized osteoporosis mouse model. NHA and HAD significantly inhibited the differentiation of osteoclasts from bone marrow-derived macrophages (BMMs) and the expression of osteoclast differentiation-related genes. At the molecular level, NHA and HAD significantly downregulated the phosphorylation of mitogen-activated protein kinase (MAPK) signaling molecules. However, Akt and NF-κB phosphorylation was inhibited only after NHA or HAD treatment. In the ovariectomy (OVX)-induced osteoporosis model, both NHA and HAD effectively improved trabecular bone structure. C-terminal telopeptide (CTX), a bone resorption marker, and RANKL, an osteoclast stimulation factor, were significantly reduced by NHA and HAD. The tartrate-resistant acid phosphatase (TRAP)-stained area, which indicates the osteoclast area, was also decreased by these compounds. These results show the potential of NHA and HAD as therapeutic agents for osteoporosis.

In this study, we investigated whether three microbial strains, Lactiplantibacillus plantarum J-135, Saccharomyces cerevisiae DAE-4, and Bacillus velezensis PBS-17, could be used to reduce mold growth and spoilage during the production of fermented feed. These microorganisms were isolated and characterized via an evaluation of their antibacterial activity, enzymatic activity, bile acid resistance, and acid tolerance. L. plantarum J-135 and S. cerevisiae DAE-4 demonstrated excellent acid tolerance and bile acid resistance, and L. plantarum J-135 exhibited antibacterial activity against Salmonella species. B. velezensis PBS-17 showed the greatest protease, cellulase, α-amylase, and phytase enzymatic activities, and displayed antibacterial activity against Fusarium solani, Aspergillus flavus, Penicillium sp., and Fusarium oxysporum. The three isolated strains were diluted to the same concentration (1:1:1) to create a culture solution, which was added to a standard feed (experimental group) to prepare fermented feed. This was compared with feed treated with a commercially available single probiotic preparation (control group 1) or a mixed microbial preparation that was composed of multiple strains, including B. subtilis. The feed treated with the single probiotic preparation spoiled after 21 days due to insufficient lactic acid bacteria growth, whereas the feed treated with the mixed microbial preparation exhibited mold growth after 14 days. The bacteria and fungi that cause spoilage during fermented feed production were effectively controlled in feed treated with L. plantarum J-135, S. cerevisiae DAE-4, and B. velezensis PBS-17. Therefore, the mixture of these three microbial strains may reduce the risk of spoilage during fermented silage and feed processing, thereby improving storage properties and stability.

Celastrus orbiculatus Thunb has been known as an ethnopharmacological medicinal plant for antitumor, anti-inflammatory, and analgesic effects. Although various pharmacological studies of C. orbiculatus extract has been reported, an anti-inflammatory mechanism study of their phytochemical constituents has not been fully elucidated. In this study, compounds 1–17, including undescribed podocarpane-type trinorditerpenoid (3), were purified from C. orbiculatus and their chemical structure were determined by high-resolution electrospray ionization mass (HRESIMS) and nuclear magnetic resonance (NMR) spectroscopic data. To investigate the anti-inflammatory activity of compounds 1–17, nitric oxide (NO) secretion was evaluated in LPS-treated murine macrophages, RAW264.7 cells. Among compounds 1–17, deoxynimbidiol (1) and new trinorditerpenoid (3) showed the most potent inhibitory effects (IC50: 4.9 and 12.6 μM, respectively) on lipopolysaccharide- (LPS-) stimulated NO releases as well as proinflammatory mediators, such as inducible nitric oxide (iNOS), cyclooxygenase- (COX-) 2, interleukin- (IL-) 1β, IL-6, and tumor necrosis factor- (TNF-) α. Its inhibitory activity of proinflammatory mediators is contributed by suppressing the activation of nuclear transcription factor- (NF-) κB and mitogen-activated protein kinase (MAPK) signaling cascades including p65, inhibition of NF-κB (IκB), extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38. Therefore, these results demonstrated that diterpenoids 1 and 3 obtained from C. orbiculatus may be considered a potential candidate for the treatment of inflammatory diseases.

The pseudostress-velocity formulation of the stationary Stokes problem allows a Raviart-Thomas mixed finite element formulation with quasi-optimal convergence and some superconvergent reconstruction of the velocity. This local postprocessing gives rise to some averaging a posteriori error estimator with explicit constants for reliable error control. Standard residual-based explicit a posteriori error estimation is shown to be reliable and efficient and motivates adaptive mesh-refining algorithms. Numerical experiments confirm our theoretical findings and illustrate the accuracy of the guaranteed upper error bounds even with reduced regularity.

Eudebeiolide B is a eudesmane-type sesquiterpenoid compound isolated from Salvia plebeia R. Br., and little is known about its biological activity. In this study, we investigated the effects of eudebeiolide B on osteoblast differentiation, receptor activator nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis in vitro and ovariectomy-induced bone loss in vivo. Eudebeiolide B induced the expression of alkaline phosphatase (ALP) and calcium accumulation during MC3T3-E1 osteoblast differentiation. In mouse bone marrow macrophages (BMMs), eudebeiolide B suppressed RANKL-induced osteoclast differentiation of BMMs and bone resorption. Eudebeiolide B downregulated the expression of nuclear factor of activated T-cells 1 (NFATc1) and c-fos, transcription factors induced by RANKL. Moreover, eudebeiolide B attenuated the RANKL-induced expression of osteoclastogenesis-related genes, including cathepsin K (Ctsk), matrix metalloproteinase 9 (MMP9) and dendrocyte expressed seven transmembrane protein (DC-STAMP). Regarding the molecular mechanism, eudebeiolide B inhibited the phosphorylation of Akt and NF-κB p65. In addition, it downregulated the expression of cAMP response element-binding protein (CREB), Bruton’s tyrosine kinase (Btk) and phospholipase Cγ2 (PLCγ2) in RANKL-induced calcium signaling. In an ovariectomized (OVX) mouse model, intragastric injection of eudebeiolide B prevented OVX-induced bone loss, as shown by bone mineral density and contents, microarchitecture parameters and serum levels of bone turnover markers. Eudebeiolide B not only promoted osteoblast differentiation but inhibited RANKL-induced osteoclastogenesis through calcium signaling and prevented OVX-induced bone loss. Therefore, eudebeiolide B may be a new therapeutic agent for osteoclast-related diseases, including osteoporosis, rheumatoid arthritis and periodontitis.

In this study, ferulic acid was investigated for its potential in suppressing TNF-α-treated inflammation and insulin resistance in adipocytes. Ferulic acid suppressed TNF-α, IL-6, IL-1β, and MCP-1. TNF-α increased p-JNK and ERK1/2, but treatment with ferulic acid (1, 10, and 50 μM) decreased p-JNK and ERK1/2. TNF-α induced the activation of IKK, IκBα, and NF-κB p65 compared to the control, but ferulic acid inhibited the activation of IKK, IκBα, and NF-κB p65. Following treatment with TNF-α, pIRS-1ser307 increased and pIRS-1tyr612 decreased compared to the control. Conversely, as a result of treatment with 1, 10, and 50 μM ferulic acid, pIRS-1ser307 was suppressed, and pIRS-1tyr612 was increased. Therefore, ferulic acid reduced inflammatory cytokine secretion by regulating JNK, ERK, and NF-κB and improved insulin resistance by suppressing pIRS-1ser. These findings indicate that ferulic acid can improve inflammation and insulin resistance in adipocytes.

Lindera obtusiloba Blume has several activities, such as anti-inflammatory, anti-allergic, anti-tumor, anti-wrinkle, and antioxidant activities. Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine that is associated with various functions, such as proliferation, invasion, inflammatory responses and functions within antioxidant defense systems. In this study, we investigated IL-6-induced STAT3 activation of lignan compounds isolated from L. obtusiloba. The structures of the isolated compounds were elucidated via spectroscopic nuclear magnetic resonance (NMR) and electrospray ionization mass spectrometry (ESI-MS). As a result, seven lignans were identified from L. obtusiloba. All the isolated compounds (1–7) were evaluated for their IL-6-induced STAT3 inhibitory effects in Hep3B cells using a luciferase reporter assay. Of the isolates, compounds 1 and 5 showed inhibitory effects against IL-6-stimulated STAT3 activation. Furthermore, the mRNA expression levels of inflammation-related genes such as CRP, IL-1b, and SOCS3 were significantly reduced by exposure to compounds 1 and 5. The protein levels of p-STAT3 and p-JAK2 in IL-6-induced U266 cells were regulated in the presence of lignans derived from Lindera obtusiloba by Western blot assay. Based on the results, this study of L. obtusiloba demonstrates that the species has promise as a bioactive candidate for the treatment of IL-6-induced STAT3-related disease.